Infarct Volume Predicts Hospitalization Costs in Anterior Circulation Large-Vessel Occlusion Stroke.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
26
04
2018
accepted:
21
10
2018
pubmed:
29
12
2018
medline:
2
1
2020
entrez:
29
12
2018
Statut:
ppublish
Résumé
Anterior circulation large-vessel occlusion stroke, one of the most devastating stroke subtypes, is associated with substantial economic burden. We aimed to identify predictors of increased acute care hospitalization costs associated with anterior circulation large-vessel occlusion stroke. Comprehensive cost-tracking software was used to calculate acute care hospitalization costs for patients with anterior circulation large-vessel occlusion stroke admitted July 2012 to October 2014. Patient demographics and stroke characteristics were analyzed, including final infarct volume on follow-up neuroimaging. Predictors of hospitalization costs were determined using multivariable linear regression including subgroup cost analyses by treatment technique (endovascular, IV tPA-only, and no reperfusion therapy) and sensitivity analyses incorporating patients initially excluded due to early withdrawal of care. Three hundred forty-one patients (median age, 69 years; interquartile range, 57-80 years; median NIHSS score, 16; interquartile range, 13-21) were included in our primary analysis. Final infarct volume, parenchymal hematoma, baseline NIHSS score, ipsilateral carotid stenosis, age, and obstructive sleep apnea were significant predictors of acute care hospitalization costs. Final infarct volume alone accounted for 20.87% of the total cost variance. Additionally, final infarct volume was consistently the strongest predictor of increased cost in primary, subgroup, and sensitivity analyses. Final infarct volume was the strongest predictor of increased hospitalization costs in anterior circulation large-vessel occlusion stroke. Acute stroke therapies that reduce final infarct volume may not only improve clinical outcomes but may also prove cost-effective.
Sections du résumé
BACKGROUND AND PURPOSE
Anterior circulation large-vessel occlusion stroke, one of the most devastating stroke subtypes, is associated with substantial economic burden. We aimed to identify predictors of increased acute care hospitalization costs associated with anterior circulation large-vessel occlusion stroke.
MATERIALS AND METHODS
Comprehensive cost-tracking software was used to calculate acute care hospitalization costs for patients with anterior circulation large-vessel occlusion stroke admitted July 2012 to October 2014. Patient demographics and stroke characteristics were analyzed, including final infarct volume on follow-up neuroimaging. Predictors of hospitalization costs were determined using multivariable linear regression including subgroup cost analyses by treatment technique (endovascular, IV tPA-only, and no reperfusion therapy) and sensitivity analyses incorporating patients initially excluded due to early withdrawal of care.
RESULTS
Three hundred forty-one patients (median age, 69 years; interquartile range, 57-80 years; median NIHSS score, 16; interquartile range, 13-21) were included in our primary analysis. Final infarct volume, parenchymal hematoma, baseline NIHSS score, ipsilateral carotid stenosis, age, and obstructive sleep apnea were significant predictors of acute care hospitalization costs. Final infarct volume alone accounted for 20.87% of the total cost variance. Additionally, final infarct volume was consistently the strongest predictor of increased cost in primary, subgroup, and sensitivity analyses.
CONCLUSIONS
Final infarct volume was the strongest predictor of increased hospitalization costs in anterior circulation large-vessel occlusion stroke. Acute stroke therapies that reduce final infarct volume may not only improve clinical outcomes but may also prove cost-effective.
Identifiants
pubmed: 30591512
pii: ajnr.A5917
doi: 10.3174/ajnr.A5917
pmc: PMC6348151
mid: NIHMS1511882
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
51-58Subventions
Organisme : NINDS NIH HHS
ID : U10 NS086489
Pays : United States
Organisme : NINDS NIH HHS
ID : U10 NS086607
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000005
Pays : United States
Informations de copyright
© 2019 by American Journal of Neuroradiology.
Références
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Stroke. 2014 Nov;45(11):3219-25
pubmed: 25190443
Stroke. 2014 Sep;45(9):2728-33
pubmed: 25096731
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e152-8
pubmed: 23253537
Stroke. 2015 Jul;46(7):1870-6
pubmed: 26012639
Neurocrit Care. 2014 Aug;21(1):20-6
pubmed: 23839704
Stroke. 2012 Dec;43(12):3238-44
pubmed: 23160876
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
J Stroke Cerebrovasc Dis. 2011 Sep-Oct;20(5):401-5
pubmed: 20656506
Stroke. 2015 Jul;46(7):1787-92
pubmed: 26060248
Stroke. 2009 Dec;40(12):3834-40
pubmed: 19834014
Stroke. 2014 Aug;45(8):2298-304
pubmed: 25005445
Stroke. 2015 May;46(5):1314-20
pubmed: 25851767
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Stroke. 2014 Jun;45(6):1791-8
pubmed: 24876261
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Ann Neurol. 2010 Oct;68(4):435-45
pubmed: 20865766
J Neurointerv Surg. 2016 Apr;8(4):423-8
pubmed: 25665984
Stroke. 2011 Nov;42(11):3271-3
pubmed: 21980210
Circulation. 2011 Mar 1;123(8):933-44
pubmed: 21262990
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):861-8
pubmed: 23954598
Neurology. 2012 Sep 25;79(13 Suppl 1):S16-21
pubmed: 23008392
J Neurointerv Surg. 2014 Jul;6(6):418-22
pubmed: 23832414
Stroke. 2012 Apr;43(4):1131-3
pubmed: 22198978